BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8631742)

  • 1. Characterization of an interleukin 6 cytokine family antagonist protein from a marine sponge, Callyspongia sp.
    Peppard JV; Loo P; Sills MA; Munster D; Pomponi SA; Wright AE
    J Biol Chem; 1996 Mar; 271(13):7281-4. PubMed ID: 8631742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.
    Chevalier S; Fourcin M; Robledo O; Wijdenes J; Pouplard-Barthelaix A; Gascan H
    J Biol Chem; 1996 Jun; 271(25):14764-72. PubMed ID: 8662918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery and characterization of an interleukin 6 cytokine family antagonist protein from a marine sponge, Callyspongia sp.
    Peppard JV; Loo P; Sills MA; Wennogle L; Wright A; Pomponi S; Cueto M
    Adv Exp Med Biol; 2001; 484():77-87. PubMed ID: 11419009
    [No Abstract]   [Full Text] [Related]  

  • 4. Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors.
    Sporeno E; Paonessa G; Salvati AL; Graziani R; Delmastro P; Ciliberto G; Toniatti C
    J Biol Chem; 1994 Apr; 269(15):10991-5. PubMed ID: 8157624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6.receptor complex.
    Ward LD; Hammacher A; Howlett GJ; Matthews JM; Fabri L; Moritz RL; Nice EC; Weinstock J; Simpson RJ
    J Biol Chem; 1996 Aug; 271(33):20138-44. PubMed ID: 8702737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
    Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
    Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional distinction of two regions of human interleukin 6 important for signal transduction via gp130.
    de Hon FD; ten Boekel E; Herrman J; Clement C; Ehlers M; Taga T; Yasukawa K; Ohsugi Y; Kishimoto T; Rose-John S
    Cytokine; 1995 Jul; 7(5):398-407. PubMed ID: 7578977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
    Jostock T; Müllberg J; Ozbek S; Atreya R; Blinn G; Voltz N; Fischer M; Neurath MF; Rose-John S
    Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
    Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
    Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A complex of the soluble interleukin-6 receptor and interleukin-6 is internalized via the signal transducer gp130.
    Graeve L; Korolenko TA; Hemmann U; Weiergräber O; Dittrich E; Heinrich PC
    FEBS Lett; 1996 Dec; 399(1-2):131-4. PubMed ID: 8980136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells.
    de Hon FD; Ehlers M; Rose-John S; Ebeling SB; Bos HK; Aarden LA; Brakenhoff JP
    J Exp Med; 1994 Dec; 180(6):2395-400. PubMed ID: 7964514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6.
    Peters M; Blinn G; Solem F; Fischer M; Meyer zum Büschenfelde KH; Rose-John S
    J Immunol; 1998 Oct; 161(7):3575-81. PubMed ID: 9759879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
    Ganapathi MK; Weizer AK; Borsellino S; Bukowski RM; Ganapathi R; Rice T; Casey G; Kawamura K
    Cell Growth Differ; 1996 Jul; 7(7):923-9. PubMed ID: 8809410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
    J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production.
    Igaz P; Horváth A; Horváth B; Szalai C; Pállinger E; Rajnavölgyi E; Tóth S; Rose-John S; Falus A
    Immunol Lett; 2000 Mar; 71(3):143-8. PubMed ID: 10722865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional expression of soluble human interleukin-11 (IL-11) receptor alpha and stoichiometry of in vitro IL-11 receptor complexes with gp130.
    Neddermann P; Graziani R; Ciliberto G; Paonessa G
    J Biol Chem; 1996 Nov; 271(48):30986-91. PubMed ID: 8940087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2?
    Kovacs E
    Biomed Pharmacother; 2003 Dec; 57(10):489-94. PubMed ID: 14637393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells.
    Sporeno E; Savino R; Ciapponi L; Paonessa G; Cabibbo A; Lahm A; Pulkki K; Sun RX; Toniatti C; Klein B; Ciliberto G
    Blood; 1996 Jun; 87(11):4510-9. PubMed ID: 8639818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.